Treatment of Graves' ophthalmopathy

被引:20
作者
Gonzalez-Garcia, Andres [1 ]
Sales-Sanz, Marco [2 ]
机构
[1] Hosp Univ Ramon & Cajal, Unidad Enfermedades Sistem Autoinmunes & Minorita, Serv Med Interna, IRYCIS, Madrid, Spain
[2] Hosp Univ Ramon & Cajal, CSUR Tumores Orbitarios & Cirugia Descompres Orbi, IRYCIS, Serv Oftalmol, Madrid, Spain
来源
MEDICINA CLINICA | 2021年 / 156卷 / 04期
关键词
Graves-Basedow disease; Graves? ophthalmopathy; Orbitopathy; Glucocorticoids; Teprotumumab; Rituximab; Tocilizumab; QUALITY-OF-LIFE; INTRAVENOUS METHYLPREDNISOLONE; ORBITAL RADIOTHERAPY; ACTIVE MODERATE; ORBITOPATHY; THERAPY; MANAGEMENT; EFFICACY; DISEASE; SAFETY;
D O I
10.1016/j.medcli.2020.07.031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graves' ophthalmopathy is an inflammatory disease with primary involvement of the extraocular muscles and the orbit. It encompasses the most common extra-thyroid manifestation in patients with GravesBasedow disease. The underlying cause is molecular mimicry with the TSH receptor in ocular fibroblasts, leading to an immuno-mediated pathogenesis. Glucocorticoids at high doses are the cornerstone in moderate-severe cases. However, some patients are corticorresistant or intolerant. In recent years, therapeutic novelties have been described in terms of the dosage of the immunosuppressive treatments used, as well as the emergence of biological therapy in this field. The objective of this review is to update the treatment of Graves' ophthalmopathy, as well as to present alternative options in patients resistant or intolerant to glucocorticoids. (c) 2020 Elsevier Espa & ntilde;a, S.L.U. All rights reserved.
引用
收藏
页码:180 / 186
页数:7
相关论文
共 55 条
[1]   Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review [J].
Acharya, Shamasunder H. ;
Avenell, Alison ;
Philip, Sam ;
Burr, Jennifer ;
Bevan, John S. ;
Abraham, Prakash .
CLINICAL ENDOCRINOLOGY, 2008, 69 (06) :943-950
[2]   Clinical Pearls and Management Recommendations for Strabismus due to Thyroid Orbitopathy [J].
Al Qahtani, Elham S. ;
Rootman, Jack ;
Kersey, James ;
Godoy, Flavia ;
Lyons, Christopher J. .
MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY, 2015, 22 (03) :307-311
[3]   MECHANISMS OF DISEASE Graves' Ophthalmopathy [J].
Bahn, Rebecca S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (08) :726-738
[4]   Understanding the immunology of Graves' ophthalmopathy - Is it an autoimmune disease? [J].
Bahn, RS .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2000, 29 (02) :287-+
[5]   Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy [J].
Bartalena, L. ;
Krassas, G. E. ;
Wiersinga, W. ;
Marcocci, C. ;
Salvi, M. ;
Daumerie, C. ;
Bournaud, C. ;
Stahl, M. ;
Sassi, L. ;
Veronesi, G. ;
Azzolini, C. ;
Boboridis, K. G. ;
Mourits, M. P. ;
Soeters, M. R. ;
Baldeschi, L. ;
Nardi, M. ;
Curro, N. ;
Boschi, A. ;
Bernard, M. ;
von Arx, G. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12) :4454-4463
[6]   The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy [J].
Bartalena, Luigi ;
Baldeschi, Lelio ;
Boboridis, Kostas ;
Eckstein, Anja ;
Kahaly, George J. ;
Marcocci, Claudio ;
Perros, Petros ;
Salvi, Mario ;
Wiersinga, Wilmar M. .
EUROPEAN THYROID JOURNAL, 2016, 5 (01) :9-26
[7]  
Bartley G B, 1994, Trans Am Ophthalmol Soc, V92, P477
[8]   Repeated peribulbar injections of triamcinolone acetonide: a successful and safe treatment for moderate to severe Graves' ophthalmopathy [J].
Bordaberry, Marcela ;
Marques, Daniela L. ;
Pereira-Lima, Julio C. ;
Marcon, Italo M. ;
Schmid, Helena .
ACTA OPHTHALMOLOGICA, 2009, 87 (01) :58-64
[9]   Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology [J].
Broen, Jasper C. A. ;
van Laar, Jacob M. .
NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (03) :167-178
[10]   Subcutaneous Tocilizumab for Thyroid Eye Disease: Simplified Dosing and Delivery [J].
Copperman, Thomas ;
Idowu, Oluwatobi O. ;
Kersten, Robert C. ;
Vagefi, M. Reza .
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2019, 35 (03) :E64-E66